DBV Technologies S.A. Stock Forecast
NASDAQ: DBVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 2:09 PM ET
DBVT analyst consensus
Consensus (7 analysts)
buy
Avg. price target
$38.63+305.78%
- Strong buy 1
- Buy 5
- Hold 0
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering DBV Technologies S.A. (2026-10-08), 6 rate the stock a buy or strong buy, 0 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $38.63, with a high estimate of $54.41 and a low estimate of $5.70. The average target implies upside of 305.8% from the current price of $9.52.
The spread between the highest and lowest targets is 854.6%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for DBVT.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 14% |
| Buy | 5 | 71% |
| Hold | 0 | 0% |
| Sell | 1 | 14% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $5.70 | -40.13% |
| Average target | $38.63 | +305.78% |
| High target | $54.41 | +471.53% |